We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
iShares MSCI USA Momentum Factor ETF
MTUM
$24.4B
| $647K | ﹤0.01% |
8,360
| – | – |
|
702
Vertex Pharmaceuticals
VRTX
$123B
| $645K | ﹤0.01% |
7,398
-207
| -3% | -$19.6K |
|
703
Voya Financial
VOYA
$9.03B
| $636K | ﹤0.01% |
22,075
| – | – |
|
|
ODP
704
DELISTED
ODP
ODP
| $634K | ﹤0.01% |
17,768
-1,432
| -7% | -$50.8K |
|
705
Ares Capital
ARCC
$13.6B
| $631K | ﹤0.01% |
40,721
-4,444
| -10% | -$68.2K |
|
|
SEE
706
DELISTED
Sealed Air
SEE
| $629K | ﹤0.01% |
13,743
+941
| +7% | +$44.3K |
|
707
Kohl's
KSS
$2.17B
| $628K | ﹤0.01% |
14,363
+8,050
| +128% | +$337K |
|
708
Tesla
TSLA
$1.21T
| $625K | ﹤0.01% |
45,975
+600
| +1% | +$8.66K |
|
|
CEMP
709
DELISTED
Cempra, Inc.
CEMP
| $624K | ﹤0.01% |
25,800
+14,450
| +127% | +$311K |
|
710
Sensient Technologies
SXT
$5.3B
| $619K | ﹤0.01% |
8,166
-950
| -10% | -$69.7K |
|
711
Evolent Health
EVH
$405M
| $615K | ﹤0.01% |
+25,000
| New | +$584K |
|
|
WFBI
712
DELISTED
WashingtonFirst Bankshares Inc
WFBI
| $614K | ﹤0.01% |
26,203
+179
| +0.7% | +$4.07K |
|
713
CBRE Group
CBRE
$43.3B
| $613K | ﹤0.01% |
21,909
+562
| +3% | +$16K |
|
714
GATX Corp
GATX
$6.62B
| $610K | ﹤0.01% |
13,699
-2,500
| -15% | -$110K |
|
|
SWN
715
DELISTED
Southwestern Energy Company
SWN
| $609K | ﹤0.01% |
44,037
+896
| +2% | +$12.4K |
|
716
Gartner
IT
$10.6B
| $608K | ﹤0.01% |
6,881
+13
| +0.2% | +$1.22K |
|
|
SRG
717
Seritage Growth Properties
SRG
$130M
| $605K | ﹤0.01% |
+11,935
| New | +$577K |
|
718
BioMarin Pharmaceuticals
BMRN
$12B
| $601K | ﹤0.01% |
6,500
-7,087
| -52% | -$667K |
|
719
General Motors
GM
$81.6B
| $601K | ﹤0.01% |
18,899
-630
| -3% | -$19.7K |
|
720
Alpha Architect US Quantitative Value ETF
QVAL
$589M
| $601K | ﹤0.01% |
25,934
-1,974
| -7% | -$45.2K |
|
721
Alpha Architect US Quantitative Momentum ETF
QMOM
$414M
| $597K | ﹤0.01% |
24,248
| – | – |
|
722
Oneok
OKE
$55.5B
| $596K | ﹤0.01% |
11,606
-194
| -2% | -$9.18K |
|
|
BKSC
723
DELISTED
Bank of South Carolina
BKSC
| $593K | ﹤0.01% |
35,912
+3,509
| +11% | +$54.9K |
|
724
Graham Holdings Company
GHC
$5.23B
| $589K | ﹤0.01% |
1,223
+440
| +56% | +$221K |
|
725
Mohawk Industries
MHK
$7.13B
| $589K | ﹤0.01% |
2,942
+66
| +2% | +$13.6K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.